LIST OF ORAL RESEARCH COMMUNICATIONS
ESVCN – European Society of Veterinary Clinical Nutrition
Thursday 10th September
09.00–09.15	ESVCN‐O‐1	Aguiar	Complications of percutaneous endoscopic gastrostomy in dogs and cats receiving corticosteroid therapy: a retrospective case–control study
09.15–09.30	ESVCN‐O‐2	German	Assessment of the adequacy of nutrient intake in obese dogs undergoing energy restriction for weight loss: a cohort study
09.30–09.45	ESVCN‐O‐3	Rochel	Endocrine profile of 402 obese dogs
09.45–10.00	ESVCN‐O‐4	Adams	Healthy ageing in Labrador retrievers: results of a prospective longitudinal study
10.00–10.15	ESVCN‐O‐5	Dobenecker	The role of phosphate in the prevention of chronic renal failure in cats
ESVCP – European Society of Veterinary Clinical Pathology
Thursday 10th September
09.00–09.15	ESVCP‐O‐1	Hillström	Serum C‐reactive protein and serum and synovial fluid interleukin 6 as possible objective biomarkers in dogs with joint disease
09.15–09.30	ESVCP‐O‐2	Goddard	Serum cytokine concentrations in virulent canine babesiosis and its association with outcome
09.30–09.45	ESVCP‐O‐3	Rautenbach	Investigation of the inflammatory immune response in dogs naturally infected with babesia rossi, using flow cytometry
09.45–10.00	ESVCP‐O‐4	Freeman	Introduction of the Biologic Variation Website and Database
10.00–10.15	ESVCP‐O‐5	Johnson	Equine Pancreatic DGGR‐Lipase has high tissue activity and specificity
10.15–10.30	ESVCP‐O‐6	Rannou	Serum amyloid a and fibrinogen concentrations in horses with different lower respiratory diseases
11.20–11.35	ESVCP‐O‐7	Hooijberg	Haematology and serum biochemistry reference intervals for the white rhinoceros, Ceratotherium simum, in South Africa
11.35–11.50	ESVCP‐O‐8	Geisen	Evaluation of the diagnostic utility of reticulocytes measured by Sysmex XT‐2000iV and the immature reticulocyte fraction in anaemic cats
11.50–12.05	ESVCP‐O‐9	Moritz	Reticulocyte hemoglobin equivalent (ret‐he), a new parameter on the procyte dx* hematology analyzer
12.05–12.20	ESVCP‐O‐10	Moritz	Reticulated platelets (rPLTs) and platelet indices as a marker of thrombopoiesis
12.20–12.35	ESVCP‐O‐11	Riondato	Comparison of three methods for the identification of stage V in canine lymphoma
12.35–12.50	ESVCP‐O‐12	Poggi	Combined flow cytometric approach for the characterization of canine small cell lymphomas
Friday 11th September, Case Presentations
14.25–14.30	Tvedten	Introduction
14.30–14.45	Case 1	Raskin	Leukocytosis in an iquana
14.45–15.00	Case 2	Knöpfler	Hematology of a white gerfalcon
15.00–15.15	Case 3	Rautenbach	Haemolytic anemia in a dog
15.15–15.30	Case 4	Rochel	Marked thrombocytosis in a dog
15.30–15.45	Case 5	Piane	Spurious platelet scattergrams
16.30–16.45	Case 6	Lagrange	Dyserythropoiesis, dog bone marrow
16.45–17.00	Case 7	Piccinelli	CSF + subarachnoid lesion in a dog
17.00–17.15
17.15–17.30	Case 9	Lilliehöök	Abdominal fluid in a dog
17.30–17.45	Case 10	Hooijberg	Anemia in an impala
17.45–18.00	Case 11	Palić	Lung mass in a dog
18.00–18.15	Case 12	Tvedten	Divergent WBC counts
Saturday 12th September
12.05–12.20	ESVCP‐O‐13	Bonsembiante	Cytology of the healthy canine and feline ocular surface: comparison between cytobrush and impression technique
12.20–12.35	ESVCP‐O‐14	Didier	Cytologic evalutations of canine intestinal lymphoma via endoscopic squash‐prep cytology
12.35–12.50	ESVCP‐O‐15	Vessieres	The use of molecular clonality for the diagnosis of thymoma in dogs
ESVIM – European Society of Veterinary Internal Medicine
Thursday 10th September
14.25–14.40	ESVIM‐O‐1	Swann	Flow cytometric characterisation of lymphocyte populations in dogs with immune‐mediated haemolytic anaemia
14.40–14.55	ESVIM‐O‐2	Priolo	Naturally occurring antibodies against canine red blood cell antigens in cats and feline red blood cell antigens in dogs
14.55–15.10	ESVIM‐O‐3	Cuq	Rabbit anti‐dog thymocyte serum as part of an immunosuppressive regimen in treating hematological immune‐mediated diseases: a retrospective study
15.10–15.25	ESVIM‐O‐4	Taylor	Detection of anti‐aspergillus immunoglobulin a in cats with upper respiratory tract aspergillosis
15.25–15.40	ESVIM‐O‐5	Girod	Comparison of two non‐invasive 2% enilconazole infusion protocols for treatment of canine sinonasal aspergillosis and importance of debridement for treatment efficacy
15.40–15.55	ESVIM‐O‐6	Vangrinsven	Endoscopic investigation of the gastroesophageal junction dynamics in dogs with brachycephalic syndrome
15.55–16.10	ESVIM‐O‐7	Leal	Tracheobronchial foreign‐bodies in cats: a retrospective study of 12 cases
16.10–16.25	ESVIM‐O‐8	Slovak	Comparison of mycophenolic acid metabolism by cat, dog, and human liver microsomes
VBPS – Veterinary Blood Pressure Society
Thursday 10th September
14.25–14.40	VBPS‐O‐1	Bijsmans	NT‐proBNP in hypertensive cats with and without target organ damage
SCH – Society of Comparative Hepatology
Thursday 10th September
14.40–14.55	SCH‐O‐1	Dirksen	Hepatocyte‐derived microRNA‐122 as an early serum biomarker of hepatocellular injury in dogs
14.55–15.10	SCH‐O‐2	Lecoindre	The use of hyaluronic acid and TGF‐ß in 83 dogs with different stage of liver fibrosis
15.10–15.25	SCH‐O‐3	Kilpatrick	Does Systemic Inflammatory Response Syndrome Predict Poor Outcome in Dogs with Hepatopathies
15.25–15.40	SCH‐O‐4	Kerridge	Investigating the prevalence of congenital portosystemic shunts in deerhounds
ESVE – European Society of Veterinary Endocrinology
Thursday 10th September
15.40–15.55	ESVE‐O‐1	van Hoek	Food‐associated factors in etiology of feline hyperthyroidism: where is the proof?
15.55–16.10	ESVE‐O‐2	Fracassi	Iodine‐restricted food in the management of feline hyperthyroidism: a non‐randomised controlled trial in 25 cats
16.10–16.25	ESVE‐O‐3	Dear	Predicting postoperative hypocalcemia in dogs following parathyroidectomy or parathyroid heat ablation
Saturday 12th September
14.25–14.40	ESVE‐O‐4	Raffan	Juvenile onset diabetes mellitus in seven labrador retriever puppies – case reports and results of candidate gene screening
14.40–14.55	ESVE‐O‐5	Forcada	A genome‐wide association study identifies novel candidate genes for susceptibility to diabetes mellitus in DSH cats
14.55–15.10	ESVE‐O‐6	Gostelow	Home blood glucose monitoring in feline diabetes mellitus: a 3‐month prospective clinical trial evaluating owner‐acceptance, quality‐of‐life and glycaemic impact
15.10–15.25	ESVE‐O‐7	Rosca	Development of an Artificial Neural Network for Prediction of Glucose Concentration in Feline Diabetes Mellitus
15.25–15.40	ESVE‐O‐8	Hoelmkjaer	A placebo‐controlled study on the effect of the GLP‐1 analogue, exenatide, on body composition, leptin and adiponectin in obese, client‐owned cats
15.40–15.55	ESVE‐O‐9	Gostelow	Evaluating the efficacy of human‐recombinant protamine zinc insulin in feline diabetes mellitus: a three month prospective clinical trial
16.30–16.45	ESVE‐O‐10	Hope	Evaluation of a novel seven‐day continuous glucose monitoring system in dogs using correlation with blood glucose readings
16.45–17.00	ESVE‐O‐11	Corradini	Evaluation of a novel flash glucose monitoring system in diabetic dogs
17.00–17.15	ESVE‐O‐12	Salesov	Evaluation of two insulin preparations and validation of a continuous glucose monitoring system for use in cats
17.15–17.30	ESVE‐O‐13	Sanders	New insights in functional zonation of the canine adrenal cortex
17.30–17.45	ESVE‐O‐14	van Opstal	The role of Sonic Hedgehog signaling in the pathogenesis of canine cortisol‐secreting adrenocortical tumors
17.45–18.00	ESVE‐O‐15	Keyte	Evaluating the use of serum N‐terminal type III pro‐collagen propeptide in the diagnosis and management of feline hypersomatotropism
ESVC – European Society of Veterinary Cardiology
Friday 11th September
14.25–14.40	ESVC‐O‐1	Kocaturk	Serum and ascitic fluid proteomes in dogs with dilated cardiomyopathy
14.40–14.55	ESVC‐O‐2	Nicolson	Cardiac biomarkers in dogs with tick paralysis (ixodes holocyclus)
14.55–15.10	ESVC‐O‐3	Gordon	Evaluation of NTproBNP, High Sensitivity Troponin I and PDK4 for the Detection of Occult DCM: A Prospective Study in 449 Doberman Pinschers
15.10–15.25	ESVC‐O‐4	Langhorn	Serum and urine cardiac troponin I in cats with renal disease
15.25–15.40	ESVC‐O‐5	Vollmar	Sudden death in Irish wolfhounds with heart disease
15.40–15.55	ESVC‐O‐6	Vollmar	Heart rates in Irish Wolfhounds with heart disease
16.30–16.45	ESVC‐O‐7	Sargo	Comparison of 2d mode and m‐mode echocardiography in persian cats performed in long‐axis and short‐axis views
16.45–17.00	ESVC‐O‐8	Orvalho	Utility of Real Time Three‐Dimentional Transesophageal Echocardiography for Balloon Valvulopasty in Dogs with Pulmonic Stenosis
17.00–17.15	ESVC‐O‐9	Yata	Evaluation of pimobendan in healthy cats: an echocardiographic study of acute cardiovascular effects
17.15–17.30	ESVC‐O‐10	Prieto‐Ramos	Use of intravenous pimobendan in cats with heart failure
17.30–17.45	ESVC‐O‐11	James	Efficacy of spironolactone (sp) following oral administration of sp in cats with heart failure: final results of the SEISICAT study.
17.45–18.00	ESVC‐O‐12	Menciotti	Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study
Saturday 12th September
09.00–09.15	ESVC‐O‐13	Baron Toaldo	Assessment of left atrial deformation and function using two‐dimensional speckle tracking echocardiography in healthy dogs and in dogs with myxomatous mitral valve disease
09.15–09.30	ESVC‐O‐14	Rishniw	Interobserver variability in two‐dimensional echocardiographic left atrial measurements is complex
09.30–09.45	ESVC‐O‐15	Kiss	Identification of cardiac‐specific fibrosis related mrna‐panel in blood samples of dogs with chronic heart failure
09.45–10.00	ESVC‐O‐16	Bode	Changes in renal cortisol metabolism are associated with the development of canine congestive heart failure
10.00–10.15	ESVC‐O‐17	Santilli	Role of right endomyocardial biopsy to characterise unexplained myocardial and rhythm disorders in the dog
10.15–10.30	ESVC‐O‐18	Baron Toaldo	Morphological and functional echocardiographic assessment of the right ventricle in normal beagles comparing with high field cardiac magnetic resonance imaging
11.20–11.35	ESVC‐O‐19	McGinnity	Assessment of Spontaneous Echo Contrast in dogs and cats using 2D colour, grey scale and colour tissue doppler imaging
11.35–11.50	ESVC‐O‐20	Novo Matos	Prevalence of patent foramen ovale in small animals: a post mortem study
11.50–12.05	ESVC‐O‐21	Pereira	Influence of feline diabetes mellitus on cardiac function
12.05–12.20	ESVC‐O‐22	Porciello	Reduction of fluoroscopic use with echoguided pacemaker implantation in the dog
12.20–12.35	ESVC‐O‐23	Szatmári	Differentiation between innocent cardiac murmurs and murmurs caused by congenital cardiac anomalies with auscultation in asymptomatic puppies
ESVNU – European Society of Veterinary Nephrology and Urology
Friday 11th September
09.00–09.15	ESVNU‐O‐10	Elliott	The effect of amlodipine treatment on vascular endothelial growth factor in feline hypertensive disease
09.15–09.30	ESVNU‐O‐2	Soerensen	Evaluation of different sampling methods and criteria for diagnosing canine urinary tract infection by quantitative bacterial culture
09.30–09.45	ESVNU‐O‐3	Dahan	Evolution of uropathogens antimicrobial resistance in a french Veterinary Teaching Hospital: A 10‐year retrospective study
09.45–10.00	ESVNU‐O‐4	Marques	Major international high‐risk resistant human Klebsiella pneumoniae lineages are causing urinary tract infections in companion animals
10.00–10.15	ESVNU‐O‐5	Sagols	In vitro dissolution of feline struvite stones with 2 diets showing different relative supersaturation values
10.15–10.30	ESVNU‐O‐6	Ghys	Evaluation of cystatin C for the detection of chronic kidney disease in cats
11.20–11.35	ESVNU‐O‐7	Muñoz	Increase of canine serum cystatin C produced by oral administration of prednisone
11.35–11.50	ESVNU‐O‐8	Muñoz	Association between plasma phosphate concentration and survival in dogs with chronic kidney disease
11.50–12.05	ESVNU‐O‐9	Steinbach	Urine protein: creatinine ratio (upc) and its relation to naturally occuring pyuria and plasma acute phase proteins in dogs
ESCG – European Society of Comparative Gastroenterology
Friday 11th September
09.00–09.15	ESCG‐O‐1	Jaillardon	Feline hypocobalaminemia: epidemiological, clinical and biological study of 259 cats
09.15–09.30	ESCG‐O‐2	Williams	Serum cobalamin concentration in geriatric cats and response to oral cobalamin supplementation is associated with differences in the composition of the fecal microbiome
09.30–09.45	ESCG‐O‐3	Maunder	Investigation into the role of campylobacter species in feline neutrophilic inflammatory bowel disease
09.45–10.00	ESCG‐O‐4	Mariani	Improvement of intestinal microbiota richness in puppies after oral hyper‐immunized plasma supplementation
10.00–10.15	ESCG‐O‐6	Moreno	Comparative analysis of the faecal virome of healthy dogs and dogs with chronic enteropathy
10.15–10.30	ESCG‐O‐8	Simpson	Characterization of antimicrobial resistance and treatment outcomes in dogs with e. coli‐associated granulomatous colitis
11.20–11.35	ESCG‐O‐7	Ruiz	Diagnostic contribution of cytological specimens obtained from biopsies during gastrointestinal endoscopy in dogs and cats: a prospective pilot study
11.35–11.50	ESCG‐O‐13	Huang	Intervention to increase physical exercise in dogs with chronic enteropathies
11.50–12.05	ESCG‐O‐9	Heilmann	Fecal S100A12 concentration predicts a lack of response to treatment in dogs with chronic enteropathies
12.05–12.20	ESCG‐O‐11	Lamoureux	Inflammatory rectal and anal stricture in small animals: an underestimated etiology. A retrospective study of ten cases (2007–2014)
12.20–12.35	ESCG‐O‐12	McLean	A comparison of ultrasonographic and clinical findings in 293 dogs with acute pancreatitis: different clinical presentation with left limb, right limb, or diffuse involvement of the pancreas
ISCAID – International Society for Companion Animal Infectious Diseases
Saturday 12th September
09.00–09.15	ISCAID‐O‐1	Solano‐Gallego	Rapid reduction of leishmania infantum‐specific antibodies during treatment in dogs with moderate disease
09.15–09.30	ISCAID‐O‐2	Solano‐Gallego	Leishmania infantum‐specific production of ifn‐gamma in stimulated blood from dogs with clinical leishmaniosis
09.30–09.45	ISCAID‐O‐3	Bouzouraa	Anaplasma platys infection in dogs: Epidemiological and clinical features from 24 naturally occurring clinical cases
09.45–10.00	ISCAID‐O‐4	Pantaleo	Prognostic values of serum electrolytes and anion gap in dogs with natural occurring leptospirosis: a cohort study in 156 dogs
10.00–10.15	ISCAID‐O‐5	Aboim	Emergence of human pathogenic Enterococcus faecalis CC2 lineages in companion animals
10.15–10.30	ISCAID‐O‐6	Sarvani	Polymerase chain reaction (PCR) survey of feline haemoplasma infections in Serbia
11.20–11.35	ISCAID‐O‐7	Broussou	Excretion of canine parvovirus type 2 (cpv‐2) during gestation and lactation in bitches and puppies
11.35–11.50	ISCAID‐O‐8	Porporato	Feline panleukopenia: clinical predictors in 177 cases (2011‐2013)
11.50–12.05	ISCAID‐O‐9	Bergmann	Antibody production as reaction to feline panleucopenia virus vaccination in healthy adult cats
12.05–12.20	ISCAID‐O‐10	Leutenegger	Spike gene mutations in feline coronavirus and their correlation to feline infectious peritonitis
12.20–12.35	ISCAID‐O‐11	Stranieri	Comparison between the diagnostic accuracy of clinico‐pathological and molecular tests for Feline Infectious Peritonitis (FIP)
12.35–12.50	ISCAID‐O‐12	Felten	Diagnostic utility of an immunocytochemical assay for feline infectious peritonitis using aqueous humor
ESVONC – European Society of Veterinary Oncology
Saturday 12th September
14.25–14.40	ESVONC‐O‐1	Sayag	Prognostic significance of morphological variant of canine diffuse large b‐cell lymphomas: a retrospective study of 49 cases
14.40–14.55	ESVONC‐O‐2	Davies	Clinical presentation and response to treatment of 63 cases of canine multicentric b‐cell lymphoma in the UK
14.55–15.10	ESVONC‐O‐3	Morris	Next generation sequencing of canine lymphoma identifies variants unique to b cell cases
15.10–15.25	ESVONC‐O‐4	Zoia	New strategies treatment in feline large granular lymphocyte lymphoma: a non‐randomised controlled trials in 20 cats
15.25–15.40	ESVONC‐O‐5	Skor	Frequency and prognostic significance of blood eosinophilia in canine mast cell tumors (MCT)
15.40–15.55	ESVONC‐O‐6	Carvalho	Association of histopathological features and COX‐2 expression in canine renal carcinomas with clinical outcome

LIST OF POSTER RESEARCH COMMUNICATIONS
ESVCN – European Society of Veterinary Clinical Nutrition
ESVCN‐P‐1	German	Inaccuracy when using tape measures to make zoometric measurements in dogs
ESVCN‐P‐2	Koizumi	Identification of the palpation site in the diagnosis of body condition score in dogs
ESVCN‐P‐3	Otsuji	Efficacy of the body condition score model in the nutritional diagnosis in dogs
ESVCN‐P‐4	Tvarijonaviciute	Alterations in plasma proteome of dogs with obesity‐related metabolic dysfunction. Preliminary results
ESVCP – European Society of Veterinary Clinical Pathology
ESVCP‐P‐1	Bau‐G	Evaluation of erythrocyte morphology in the domestic ferret (Mustela putorius furo)
ESVCP‐P‐2	Bertazzolo	Thoracic non‐chylous lymphorrhagic effusion in cats
ESVCP‐P‐3	Conway	Analytical performance of a new point‐of care dry chemistry analyser and method of comparison with an established automated wet analyser
ESVCP‐P‐4	Tvarijonaviciute	Validation of the methods for total oxidant status and total antioxidant capacity measurement in mussels
ESVCP‐P‐5	Gavazza	Pre‐analytical errors in laboratory testing of canine and feline samples. Occurrence of hemolysis, lipemia, and icterus
ESVCP‐P‐6	Ghisleni	Diagnostic cytology of Myxozoan infections of fish
ESVCP‐P‐7	Giordano	Hematological, serum biochemical and electrophoretic values in captive Egyptian fruit bats (Rousettus Aegyptiacus)
ESVCP‐P‐8	Giraldi	Evaluation of proteinuria in cats: comparison between Coomassie Brilliant Blue and Pyrogallol Red Molybdate
ESVCP‐P‐9	Kohn	Serial Crossmatching in Feline Transfusion Patients
ESVCP‐P‐10	Schmidt	Hypercholesterolaemia in older cats is not associated to hatoglobin and serum amyloid A concentration
ESVCP‐P‐11	Lubas	Selection of canine blood donors considering epidemiological issues in Italy. A working group consensus on infectious diseases screening
ESVCP‐P‐12	Moreira dos Santos Schmidt	Hematological profile, plasmatic protein and fibrinogen in Holstein cows under heat stress
ESVCP‐P‐13	Miniscalco	Long‐term preservation of urine sediment with formaldehyde: does it work?
ESVCP‐P‐14	Moretti	Laboratory reference intervals of holstein lactating cows at 3 and 30 days post‐partum
ESVCP‐P‐15	Paltrinieri	Sodium‐dodecylsulphate agarose gel electrophoresis (SDS‐AGE) as a tool for monitoring the pattern of proteinuria in dogs with leishmaniasis
ESVCP‐P‐16	Peres Rubio	C‐reactive protein concentration in female dogs submitted to conventional and minimal invasive ovariohysterectomy
ESVCP‐P‐17	Sævik	The effect of breed, sex, age and body weight on feline serum biochemistry variables
ESVCP‐P‐18	Scarpa	Reproducibility of urine sediment examination using two different methods
ESVCP‐P‐19	Gavazza	Prevalence of dog erythrocyte antigens 4 and 7 in Italian canine blood donors using gel agglutination technique
ESVCP‐P‐20	Tvarijonaviciute	Effects of seasonality on blood analytes related with metabolism in Pyrenean chamois (Rupicaprapyrenaica)
ESVCP‐P‐21	Vilhena	Serum acute phase proteins in Mycoplasma spp. infected cats
ESVCP‐P‐22	Rossi	Reproducibility of urine sediment examination using different volumes of sample
ESVCP‐P‐23	Weber	Fast and simple mdr1‐genotyping in dogs: towards a point‐of‐care test
ESVCP‐P‐24	Trumel	Comparison of canine and feline blood/plasma creatinine measurements obtained with the Nova Statsensor point‐of‐care analyzer and the Vitros 350
ESVCP‐P‐25	Trumel	Urine protein electrophoresis on canine urine stored on absorbent paper
ESVIM – European Society of Veterinary Internal Medicine
ESVIM‐P‐1	Breu	Analyses of cerebrospinal fluid (CSF) samples of 210 dogs with neurological symptoms
ESVIM‐P‐2	Hugonnard	Pet owners use of the Internet for their pets' health
ESVIM‐P‐3	Cocci	Evaluation of topic 1% clotrimazole cream as the only treatment for canine sinonasal aspergillosis: 9 cases (2008–2015)
ESVIM‐P‐4	Diquélou	Survey of euthanasia practices of dogs and cats by French veterinary practitioners
ESVIM‐P‐5	Karnezi	Canine pancytopenia: a retrospective study of 119 cases
ESVIM‐P‐6	García‐Guasch	Differences of breathing patterns between cats with laryngeal masses and feline bronchial diseases by using barometric whole‐body plethysmography
ESVIM‐P‐7	Hoummady	Risk factors for mortality in aged guide dogs
ESVIM‐P‐8	Johnson	Laryngoscopy in coughing dogs
ESVIM‐P‐9	Johnson	Bronchiectasis in dogs
ESVIM‐P‐10	Mclean	A Retrospective Study of Chronic Respiratory Disease in 126 Dogs Presenting to a Private South African Veterinary Clinic
ESVIM‐P‐11	McPartland	Sterile steroid‐responsive lymphadenitis in 36 dogs
ESVIM‐P‐12	Planellas	Oxidative stress values in brachycephalic dogs with upper airway obstruction
ESVIM‐P‐13	Roels	Chemokine (cc‐motif) ligand 2 as a prognostic serum marker in canine idiopathic pulmonary fibrosis
ESVIM‐P‐14	Roels	Standardized characterization of thoracic high‐resolution computed tomographic findings in west highland white terrier with canine idiopathic pulmonary fibrosis and comparison between sedated and anesthetized examinations
ESVIM‐P‐15	Schmitz	Retrospective characterization of mesenterial purulent lymphadenitis and lymph node abscesses in dogs reveals an increased risk for the small Munsterlander
ESVIM‐P‐16	Schulz	Clinical and laboratory parameters in dogs with canine infectious respiratory disease (cird)
ESVIM‐P‐17	Viitanen	Peripheral blood lymphocyte subpopulations in irish wolfhounds with pneumonia
VBPS – Veterinary Blood Pressure Society
VBPS‐P‐1	Larsson	Comparison of measurement of systolic arterial blood pressure by Doppler method in different body positions in conscious dogs
VBPS‐P‐2	Stepien	Repeatability of hypertension diagnosis based on noninvasive blood pressure assessment in clinical canine patients
SCH – Society of Comparative Hepatology
SCH‐P‐1	Sato	Gallbladder agenesis in 15 dogs
ESVE – European Society of Veterinary Endocrinology
ESVE‐P‐1	Decôme	Prevalence and Clinical Features of Naturally Occurring Hypoadrenocorticism in Great Pyrenees in a Referred Population in Montreal, Canada: 11 Cases (2005–2014)
ESVE‐P‐3	Spence	The use of a novel latex immunoagglutination inhibition method for haemoglobin A1c measurements in dogs
ESVE‐P‐4	Wehner	Validation of an enzyme fluorescence assay (ELFA) to measure total thyroxine in dogs and cats
ESVC – European Society of Veterinary Cardiology
ESVC‐P‐1	Baisan	The diagnostic value of cardio‐thoracic ratio for detecting the heart size changes in dogs
ESVC‐P‐2	Batista	Electrocardiographic changes during normal canine puerperium
ESVC‐P‐3	Batista	Echocardiographic assessment of pregnant queens
ESVC‐P‐4	Caro‐Vadillo	Reproducibility and influence of age of tricuspid annular plane systolic excursion (TAPSE) in beagle dogs
ESVC‐P‐5	Bomassi	Tetralogy of Fallot in dogs and cats: a retrospective study of 31 cases (2003–2014)
ESVC‐P‐6	Chiu	Age‐related changes in vertebral heart scale and echocardiographic indices in healthy geriatric cats
ESVC‐P‐7	Carnabuci	Irreversible pulmonary hypertension and tricuspid regurgitation in young cats secondary to different lungworm infections
ESVC‐P‐8	Damoiseaux	Quantification of systolic and diastolic right ventricular function by conventional echocardiography and speckle tracking imaging: a prospective study in 104 healthy dogs with documented pulmonary arterial pressure and left ventricular function
ESVC‐P‐9	Itikawa	Left ventricle function assessment by non‐invasive dp/dt in dogs with chronic mitral valve disease
ESVC‐P‐10	Pariaut	Success of pulmonary balloon valvuloplasty in relation to valve anatomy in dogs: a multicenter follow up study
ESVC‐P‐11	Giorgi	Prevalence of hypertrophic cardiomyopathy (hcm) in feline population examined by the osservatorio italiano hcm felina
ESVC‐P‐12	Lobo	Epidemiological characterization of a Portuguese population of dogs with canine chronic mitral valve disease: 542 cases
ESVC‐P‐13	Locatelli	Anemia in dogs with mitral valve disease: prevalence and associated risk factors
ESVC‐P‐14	Schwartz	Left atrial dysfunction in dogs with symptomatic chronic mitral valve disease
ESVC‐P‐15	Martinelli	Cardiorenal syndrome in dogs with mitral valve disease: a prospective study
ESVC‐P‐16	Monzo	Prevalence of hypertrophic cardiomyopathy on a population of 150 cats
ESVC‐P‐19	Olsen	Increased serum C‐reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease
ESVC‐P‐20	Saponaro	Cardiovascular effects of medetomidine in stage b2 myxomatous mitral valve disease
ESVC‐P‐21	Ventura	Transarterial Patent Ductus Arteriosus Occlusion Using Different Devices in 25 Dogs
ESVC‐P‐22	Vezzosi	Comparison of two echocardiographic views for evaluating the right pulmonary artery distensibility index in dogs
ESVNU – European Society of Veterinary Nephrology and Urology
ESVNU‐P‐2	Grandemange	Long term survey of the effect of imidapril on the glomerular filtration rate in cats suffering from chronic kidney disease
ESCG – European Society of Comparative Gastroenterology
ESCG‐P‐1	Allenspach	Hypovitaminosis D is associated with poor outcome in dogs with protein losing enteropathy
ESCG‐P‐2	Bojanic	Pathogenicity investigation of Campylobacter jejuni, C. upsaliensis and C. helveticus isolated from dogs and cats using Galleria mellonella larvae
ESCG‐P‐3	Grellet	The influence of a moderate intensity short duration exercise on serum C‐reactive protein and fecal S100A12 concentrations in adult dogs
ESCG‐P‐4	Solomon	Assessment of image quality produced by a novel gi imaging device used in client‐owned dogs
ESCG‐P‐6	Liu	Establishment of a severity scoring system for outcome prediction in dogs with pancreatitis
ESCG‐P‐7	Luckschander‐Zeller	The canine intestine – important for independant glucocorticoid metabolism?
ESCG‐P‐8	O'Brien	Cardiac injury detected by troponin is associated with pancreatitis detected by DGGR‐lipase in dogs and cats
ESCG‐P‐9	Sharman	Comparison of confocal endomicroscopy and other diagnostic modalities to detect intracellular helicobacter in dogs
ESCG‐P‐10	Toresson	Oral cobalamin supplementation in cats with hypocobalaminemia
ESCG‐P‐11	Leça Jacinto	Evaluation of Microparticle Procoagulant Activity in Dogs with Idiopathic Inflammatory Bowel Disease
ESCG‐P‐12	Jergens	Analysis of the ileal and colonic mucosal microbiota in canine chronic enteropathies
ISCAID – International Society for Companion Animal Infectious Diseases
ISCAID‐P‐2	Attipa	The first prevalence study of haemoplasma species, leishmania spp., bartonella henselae, ehrlichia/anaplasma spp., feline immunodeficiency virus and feline leukaemia virus in cats from cyprus
ISCAID‐P‐3	Bergmann	Prevalence of Bartonella species infections in cats in Southern Germany
ISCAID‐P‐4	Felten	Detection of feline coronavirus spike gene mutations as a tool to diagnose feline infectious peritonitis
ISCAID‐P‐5	Freiche	Sequencing of 3c and spike genes in Feline Infectious Peritonitis: Which samples are the most relevant for analysis ? A retrospective study of 33 cases from 2008 to 2014.
ISCAID‐P‐6	Lo Piccolo	Occurrence of MethicillinResistant Staphylococcus aureus (MRSA) isolates from clinical specimens of household dogs
ISCAID‐P‐8	Müller Pereira	Molecular detection of Haemotropic Mycoplasmas infecting domestic cats from southern Chile
ISCAID‐P‐9	Pacheco	Myocardial lesions in dogs with visceral leishmaniasis
ISCAID‐P‐10	Planellas	Urinary adverse effects of allopurinol treatment in dogs with leishmaniosis: a prospective study (preliminary data).
ISCAID‐P‐11	Rehbein	Giardia duodenalis in dogs and cats: an epidemiological study
ISCAID‐P‐12	Theron	Canine parvoviral enteritis: a retrospective study of 147 cases (2003–2013)
ISCAID‐P‐13	Thibault	Evaluation of the impact of residual Maternally Derived Antibodies against Canine Parvovirus on the efficacy of a standard primary vaccination protocol
ISCAID‐P‐14	Tozon	C‐reactive protein elevation in dogs naturally infected with bacterium anaplasma phagocytophilum
ESVONC – European Society of Veterinary Oncology
ESVONC‐P‐1	Baril	Evaluation of environmental exposure to vincristine and cyclophosphamide in veterinary medicine
ESVONC‐P‐2	Carvalho	Intratumoral CD3+ T‐lymphocytes immunoexpression and its association with c‐kit and angiogenesis in malignant canine mammary tumors: a multivariate survival analysis
ESVONC‐P‐4	Zoia	Epidemiological data of feline large granular lymphocyte lymphoma: a case control study in 176 cats
ESVONC‐P‐5	Carvalho	Intratumoral FoxP3 expression in malignant canine mammary tumors: its association with clinicopathological parameters, angiogenesis and prognosis